Viruses and atherosclerosis: A critical review of the epidemiologic evidence

American Heart Journal

Volumn 138, Issue 5 II, 1999, Pages

  Nieto, F J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKING; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISEASE ASSOCIATION; HERPES; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032738818     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70274-7     Document Type: Conference Paper

References (68)

1. Nieto FJ. Infections and atherosclerosis: new clues from an old hypothesis? Am J Epidemiol 1998;148:937-48.
2. Benditt EP, Benditt JM. Evidence of a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A 1973;70:1753-6.
3. Fabricant CG, Fabricant J, Litrenta MM, et al. Virus-induced atherosclerosis. J Exp Med 1978;148:335-40.
4. Martin GM, Sprague CA, Norwood TH, et al. Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. Am J Pathol 1974;74:137-54.
5. Pearson TA, Wang BA, Solez K, et al. Clonal characteristics of fibrous plaques and fatty streaks from human aortas. Am J Pathol 1975;81:379-87.
6. Pearson TA, Dillma JM, Solez K, et al. Clonal characteristics of cutaneous scars and implications for atherogenesis. Am J Pathol 1981;102:49-54.
7. Fabricant CG, Fabricant J. Atherosclerosis induced by infection with Marek's diseases herpesvirus (MDV) in chickens. Am Heart J 1999;138:S465-8.
8. Hendrix MGR, Salimans MMM, van Boven CPA, et al. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990;136:23-8.
9. Melnick JL, Adam E, DeBakey ME. Cytomegalovirus and atherosclerosis. Eur Heart J 1993;14(suppl K):30-8.
10. Melnick JL, Hu C, Burek J, et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994;42:170-4.
11. Melnick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA 1990;263:2204-7.
12. Nicholson AC, Hajjar DP. Herpesviruses in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol 1998;18:339-48.
13. Fabricant CG, Krook L, Gillespie JH. Virus-induced cholesterol crystals. Science 1973;181:566-7.
14. Hajjar DP, Fabricant CG, Minick CR, et al. Virus induced atherosclerosis: herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol 1986;122:62-70.
15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
16. Span AHM, Van Boven CPA, Bruggeman CA. The effect of cytomegalovirus infection on the adherence of polymorphonuclear leukocytes to endothelial cells. Eur J Clin Invest 1989;19:542-8.
17. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391-4.
18. Bruggeman CA, Debie WHM, Muller AD, et al. Cytomegalovirus alters the von Willebrand factor content in human endothelial cells. Thromb Haemost 1988;59:264-8.
19. van Dam-Mieras MCE, Muller AD, van Hinsbergh VWM, et al. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 1992;68:364-70.
20. Nicholson AC, Hajjar DP. Viral activation of the coagulation cascade. Am Heart J 1999;138:S461-4.
21. Lancet Editors. Virus infections and atherosclerosis [editorial]. Lancet 1978;2:821-2.
22. Adam E, Melnick JL, Probtsfield JL, et al. High level of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987;2:291-3.
23. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
24. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095-103.
25. Cour MI, López de Atalaya FJ, Palau L, et al. Lack of serological association between herpesvirus and atherosclerosis [Letter]. Lancet 1989;1:279.
26. Dummer S, Lee A, Breinig MK, et al. Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J Med Virol 1994;44:305-9.
27. Li B, Xu C, Wang Q. The detection of the antibodies of human cytomegalovirus in the sera of patients with coronary heart disease [in Chinese]. Chung Hua Nei Ko Tsa Chih 1996;35:741-3.
28. Liuzzo G, Caligiuri G, Grillo RL, et al. Helicobacter pylori and cytomegalovirus infections are strongly associated with atherosclerosis, but are not responsible for the instability of angina [abstract]. J Am Coll Cardiol 1997;29(suppl A):217A.
29. Adler SP, Hur JK, Wang JB, et al. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis 1998;177:209-12.
30. Rothenbacher D, Hoffmeister A, Bode G, et al. Infection with cytomegalovirus and risk of coronary heart disease under consideration of markers of systemic inflammation [abstract]. Circulation 1998;98:876.
31. Smieja M, Cronin L, Yosuf S, et al. Exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus in patients with acute coronary syndromes [abstract]. Abstract of the IDSA Annual Meeting, 1998.
32. Anderson JL, Carlquist JF, Muhlestein JB, et al. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998;32(1):35-41.
33. Blum A, Giladi M, Weingerg M, et al. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 1998;81:866-8.
34. Siscovick DS, Schwartz SM, Corey L, et al. Antibody to Chlamydia pneumoniae, herpes simplex virus type 1, cytomegalovirus and incident myocardial infarction and coronary heart disease death: the Cardiovascular Health Study [abstract]. Circulation 1998;97:814.
35. Sorlie PD, Adam E, Melnick SL, et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol 1994;42:337.
36. Nieto FJ, Adam E, Sorlie P, et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996;94:922-7.
37. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624-30.
38. Grattan MT, Moreno Cabral CE, Starnes VA, et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-6.
39. Cameron DE, Greene PS, Alejo D, et al. Postoperative cytomegalovirus (CMV) infection and older donor age predispose to coronary atherosclerosis after heart transplantation [abstract]. Circulation 1989;80(suppl II):526.
40. McDonald K, Rector TS, Braunlin EA, et al. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989;64:359-62.
41. Gaudin PB, Rayburn BK, Hutchins GM, et al. Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol 1994;18:338-46.
42. Koskinen P, Lemstrom K, Mattila S, et al. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft. Clin Transplant 1996;10:487-93.
43. Everett JP, Hershberger RE, Norman DJ, et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 1992;11:S133-7.
44. Gao S-Z, Hunt SA, Alderman EL, et al. Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease. J Am Coll Cardiol 1997;29:623-9.
45. Hauptman PJ, Davis SF, Miller S, et al. The role of nonimmune risk factors in the development and progression of graft arteriosclerosis: preliminary insights from a multicenter intravascular ultrasound study. J Heart Lung Transplant 1995;14:S238-42.
46. Hosenpud JD. Coronary artery disease following heart transplantation and its relationship to cytomegalovirus. Am Heart J 1999;138:S469-72.
47. Wu T-C, Hruban RH, Ambinder RF, et al. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol 1992;140:739-47.
48. Billingham ME. Graft coronary disease: the lesions and the patients. Transplant Proc 1989;21:3665-6.
49. Weis M, von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 1997;96:2069-77.
50. Nieto FJ, Sorlie P, Comstock GW, et al. Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link? Arterioscler Thromb Vasc Biol 1997;17:1780-5.
51. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
52. Burch GE, Harb JM, Hiramoto Y, et al. Viral infection of the aorta of man associated with early atherosclerotic changes. Am Heart J 1973;86:523-34.
53. Nicholls AC, Thomas M. Coxsackie virus infection in acute myocardial infarction. Lancet 1977;I:883-4.
54. O'Neill D, McArthur JD, Kennedy JA, et al. Coxsackie B virus infection in coronary care unit patients. J Clin Pathol 1983;36:658-61.
55. Griffiths PD, Hannington G, Booth JC. Coxsackie B virus infections and myocardial infarction: results from a prospective, epidemiologically controlled study. Lancet 1980;1:1387-9.
56. Roivainen M. Enterovirus and myocardial infarction. Am Heart J 1999;138:S479-83.
57. Valtonen VV. The role of infections in atherosclerosis. Am Heart J 1999;138:S431-3.
58. Syrjänen J, Valtonen VV, Iivanainen M, et al. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. BMJ 1988;296:1156-60.
59. Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 1989;225:293-6.
60. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease: a possible trigger for acute myocardial infarction? Int J Epidemiol 1978;7:231-9.
61. Zhu J, Quyyumi AA, Norman JE, et al. Total pathogen burden contributes incrementally to coronary artery disease risk and to C-reactive protein levels [abstract]. Circulation 1998;98(suppl I):I-42.
62. Friedman HM, Macarak EJ, MacGregor RR, et al. Virus infection of endothelial cells. J Infect Dis 1981;143:266-73.
63. Freeman J, Hutchinson GB. Prevalence, incidence and duration. Am J Epidemiol 1980;112:707-23.
64. Pearson TA. Coronary arteriography in the study of the epidemiology of coronary heart disease. Epidemiol Rev 1984;6:140-66.
65. Gullen WH, Bearman JE, Johnson EA. Effects of misclassification in epidemiologic studies. Public Health Rep 1968;83:914-8.
66. Strong JP, McGill HC. The pediatric aspects of atherosclerosis. J Atheroscler Res 1969;9:251-65.
67. Mattila KJ, Valtonen VV, Nieminen MS, et al. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998;28:719-34.
68. Bruggeman CA. Cytomegalovirus and latency: an overview. Virchows Arch B Cell Pathol 1993;64:325-33.